New Meds and Tech: Tandem® Diabetes Care Control-IQ Technology

In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery…

Read More

Late Effects of Treatments for Childhood Cancer (NIH-National Cancer Institute)

Endocrine Late-Effects of Treatment for Childhood Cancer

Read More

Child with Suspected Hypocalcemia

Primary Care provider guidelines for referral.

Read More

New Meds and Tech: New Cortisol Assays, New Threshold for Adrenal Insufficiency

 

Read More

New Meds and Tech: Newer Insulin Preparation – Faster Insulin Aspart (Fiasp)

Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before…

Read More

New Meds and Tech: Increlex

In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy,…

Read More

New Meds and Tech: Glucagon Preparations

The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly)…

Read More

New Meds and Tech: Vitamin D Preparations and Safety Issues

Vitamin D is a fat soluble vitamin that is essential for maintaining bone health and also has other potential health benefits. While some of these other…

Read More

New Meds and Tech: Tirosint-SOL

Levothyroxine sodium oral solution (Tirosint-SOL) has now been approved by the FDA and is available for use in the US. Please click on the link below for…

Read More

ADA Standards of Medical Care in Diabetes – 2020

Annually revised Standards of Diabetes Care published by ADA in Diabetes Care.

Read More